Genetic Epidemiology of Acute Respiratory Distress Syndrome: Implications for Future Prevention and Treatment

Clinics in Chest Medicine

Volumn 27, Issue 4, 2006, Pages 705-724

  Gong, Michelle Ng ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER; CLARA CELL PROTEIN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 10; INTERLEUKIN 6; LUNG SURFACTANT; LYMPHOTOXIN; MANNOSE BINDING LECTIN; MYOSIN LIGHT CHAIN KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALMETEROL; SURFACTANT PROTEIN B; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; VASCULOTROPIN;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANALYTIC METHOD; ASTHMA; BIOTECHNOLOGY; BREAST CANCER; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE MARKER; DISEASE PREDISPOSITION; GENE; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HAPLOTYPE; HUMAN; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PATHOGENESIS; PHARMACOEPIDEMIOLOGY; PHARMACOGENOMICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

GENE THERAPY; HUMANS; INCIDENCE; POLYMORPHISM, GENETIC; PROGNOSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 33751026204     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2006.07.001     Document Type: Review

References (91)

1. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N Engl J Med 342 18 (2000) 1334-1349
2. Hudson L.D., Milberg J.A., Anardi D., et al. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151 2 Pt 1 (1995) 293-301
3. Fowler A.A., Hamman R.F., Good J.T., et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 98 5 Pt 1 (1983) 593-597
4. Rubenfeld G.D., Caldwell E., Peabody E., et al. Incidence and outcomes of acute lung injury. N Engl J Med 353 16 (2005) 1685-1693
5. Hug C., and Lodish H.F. Medicine. Visfatin: a new adipokine. Science 307 5708 (2005) 366-367
6. Matthay M.A., and Zimmerman G.A. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 33 4 (2005) 319-327
7. Prabhakaran P., Ware L.B., White K.E., et al. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol 285 1 (2003) L20-L28
8. Bersten A.D., Hunt T., Nicholas T.E., et al. Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute respiratory failure. Am J Respir Crit Care Med 164 4 (2001) 648-652
9. Marks J.D., Marks C.B., Luce J.M., et al. Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis 141 1 (1990) 94-97
10. Meduri G.U., Headley S., Kohler G., et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107 4 (1995) 1062-1073
11. Ware L.B., Conner E.R., and Matthay M.A. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med 29 12 (2001) 2325-2331
12. Khoury M.J., and Yang Q. The future of genetic studies of complex human diseases: an epidemiologic perspective. Epidemiology 9 3 (1998) 350-354
13. Suter P.M., Suter S., Girardin E., et al. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 145 5 (1992) 1016-1022
14. Ito R.K., and Demers L.M. Pharmacogenomics and pharmacogenetics: future role of molecular diagnostics in the clinical diagnostic laboratory. Clin Chem 50 9 (2004) 1526-1527
15. Ellsworth D.L., and Manolio T.A. The emerging importance of genetics in epidemiologic research. II. Issues in study design and gene mapping. Ann Epidemiol 9 2 (1999) 75-90
16. Marshall R.P., Webb S., Bellingan G.J., et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 166 5 (2002) 646-650
17. Harding D., Baines P.B., Brull D., et al. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am J Respir Crit Care Med 165 8 (2002) 1103-1106
18. Orfanos S.E., Armaganidis A., Glynos C., et al. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation 102 16 (2000) 2011-2018
19. Fourrier F., Chopin C., Wallaert B., et al. Angiotensin-converting enzyme in human adult respiratory distress syndrome. Chest 83 4 (1983) 593-597
20. Imai Y., Kuba K., Rao S., et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436 7047 (2005) 112-116
21. Frerking I., Sengler C., Gunther A., et al. Evaluation of the -26G > A CC16 polymorphism in acute respiratory distress syndrome. Crit Care Med 33 10 (2005) 2404-2406
22. Nomori H., Horio H., Fuyuno G., et al. Protein 1 (Clara cell protein) serum levels in healthy subjects and patients with bacterial pneumonia. Am J Respir Crit Care Med 152 2 (1995) 746-750
23. Marshall R.P., Webb S., Hill M.R., et al. Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest 121 3 Suppl (2002) 68S-69S
24. Sutherland A.M., Walley K.R., Manocha S., et al. The association of interleukin 6 haplotype clades with mortality in critically ill adults. Arch Intern Med 165 1 (2005) 75-82
25. Nonas S.A., Finigan J.H., Gao L., et al. Functional genomic insights into acute lung injury: role of ventilators and mechanical stress. Proc Am Thorac Soc 2 3 (2005) 188-194
26. Gong M.N., Zhou W., Williams P.L., et al. Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome. Eur Respir J 27 4 (2006) 674-681
27. Gallagher P.M., Lowe G., Fitzgerald T., et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 58 2 (2003) 154-156
28. Schroder O., Laun R.A., Held B., et al. Association of interleukin-10 promoter polymorphism with the incidence of multiple organ dysfunction following major trauma: results of a prospective pilot study. Shock 21 4 (2004) 306-310
29. Reid C.L., Perrey C., Pravica V., et al. Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome. Crit Care Med 30 10 (2002) 2216-2221
30. Jaber B.L., Rao M., Guo D., et al. Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 25 5 (2004) 212-219
31. Armstrong L., and Millar A.B. Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome. Thorax 52 5 (1997) 442-446
32. Donnelly T.J., Meade P., Jagels M., et al. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med 22 5 (1994) 768-776
33. Garred P, J JS, Quist L, et al. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Strom J 2003;188(9):1394-403.
34. Fidler K.J., Wilson P., Davies J.C., et al. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med 30 7 (2004) 1438-1445
35. Eutamene H., Theodorou V., Schmidlin F., et al. LPS-induced lung inflammation is linked to increased epithelial permeability: role of MLCK. Eur Respir J 25 5 (2005) 789-796
36. Parker J.C. Inhibitors of myosin light chain kinase and phosphodiesterase reduce ventilator-induced lung injury. J Appl Physiol 89 6 (2000) 2241-2248
37. Ye S.Q., Simon B.A., Maloney J.P., et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 171 4 (2005) 361-370
38. Quasney M.W., Waterer G.W., Dahmer M.K., et al. Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia. Crit Care Med 32 5 (2004) 1115-1119
39. Lin Z., Pearson C., Chinchilli V., et al. Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet 58 3 (2000) 181-191
40. Gong M.N., Wei Z., Xu L.L., et al. Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest 125 1 (2004) 203-211
41. Doyle I.R., Bersten A.D., and Nicholas T.E. Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failure. Am J Respir Crit Care Med 156 4 Pt 1 (1997) 1217-1229
42. Epaud R., Ikegami M., Whitsett J.A., et al. Surfactant protein B inhibits endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol 28 3 (2003) 373-378
43. Floros J., Veletza S.V., Kotikalapudi P., et al. Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome. Biochem J 305 Pt 2 (1995) 583-590
44. Gong M.N., Zhou W., Williams P.L., et al. -308GA and TNFB polymorphisms in acute respiratory distress syndrome. Eur Respir J 26 3 (2005) 382-389
45. Roumen R.M., Hendriks T., van der Ven-Jongekrijg J., et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 218 6 (1993) 769-776
46. Mira J.P., Cariou A., Grall F., et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282 6 (1999) 561-568
47. Watanabe E., Hirasawa H., Oda S., et al. Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit Care Med 33 1 (2005) 89-97 [discussion: 242-3]
48. Barber R.C., Aragaki C.C., Rivera-Chavez F.A., et al. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 41 11 (2004) 808-813
49. Medford A.R., Keen L.J., Bidwell J.L., et al. Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome. Thorax 60 3 (2005) 244-248
50. Thickett D.R., Armstrong L., and Millar A.B. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med 166 10 (2002) 1332-1337
51. Silverman E.K., and Palmer L.J. Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol 22 6 (2000) 645-648
52. Gong MN, Zhou W, Williams PL, et al. Mannose binding lectin-2 gene and acute respiratory distress syndrome. Crit Care Med, in press.
53. Jia S.H., Li Y., Parodo J., et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113 9 (2004) 1318-1327
54. Pritchard J.K., and Cox N.J. The allelic architecture of human disease genes: common disease-common variant or not?. Hum Mol Genet 11 20 (2002) 2417-2423
55. Schork N. The future of genetic case-control studies. In: Rao D.C., and Province M.A. (Eds). Genetic dissection of complex traits (2001), Academic Press 191-212
56. Cardon L.R., and Abecasis G.R. Using haplotype blocks to map human complex trait loci. Trends Genet 19 3 (2003) 135-140
57. Risch N., and Merikangas K. The future of genetic studies of complex human diseases. Science 273 5281 (1996) 1516-1517
58. Bogardus Jr. S.T., Concato J., and Feinstein A.R. Clinical epidemiological quality in molecular genetic research: the need for methodological standards. JAMA 281 20 (1999) 1919-1926
59. Boffetta P. Molecular epidemiology. J Intern Med 248 6 (2000) 447-454
60. Chan K.C., Tang N.L., Hui D.S., et al. Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study. BMC Infect Dis 5 1 (2005) 26
61. Gao L., Grant A., Halder I., et al. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol 34 4 (2006) 487-495
62. Bajwa EY, Yu CL, Gong MN, et al. PBEF gene polymorphisms and risk of developing ARDS. Crit Care Med 2006.
63. Max M.P., Pison U., and Floros J. Frequency of SP-B and SP-A1 gene polymorphisms in acute respiratory distress syndrome (ARDS). Appl Cardiopulm Pathophysiol 6 (1996) 111-118
64. Brekelmans C.T., Seynaeve C., Menke-Pluymers M., et al. Survival and prognostic factors in BRCA1-associated breast cancer. Ann Oncol 17 3 (2006) 391-400
65. Rubenfeld G.D., Caldwell E., Granton J., et al. Interobserver variability in applying a radiographic definition for ARDS. Chest 116 5 (1999) 1347-1353
66. Esteban A., Fernandez-Segoviano P., et al. Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings. Ann Intern Med 141 6 (2004) 440-445
67. Ferguson N.D., Frutos-Vivar F., Esteban A., et al. Acute respiratory distress syndrome: underrecognition by clinicians and diagnostic accuracy of three clinical definitions. Crit Care Med 33 10 (2005) 2228-2234
68. Hennekens C.H., and Buring J.E. Case-control studies. In: Hennekens C.H., and Buring J.E. (Eds). Epidemiology in medicine (1987), Little, Brown and Company, Boston 132-152
69. Li C. Large random mating population. First course in population genetics. Boxwood Press; 1976. p. 1-15.
70. Moss M., and Mannino D.M. Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979-1996). Crit Care Med 30 8 (2002) 1679-1685
71. Veletza S.V., Rogan P.K., TenHave T., et al. Racial differences in allelic distribution at the human pulmonary surfactant protein B gene locus (SP-B). Exp Lung Res 22 4 (1996) 489-494
72. Govan V.A., Constant D., Hoffman M., et al. The allelic distribution of -308 tumor necrosis factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer 6 (2006) 24
73. Lipscombe R.J., Sumiya M., Hill A.V., et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1 9 (1992) 709-715
74. Gabriel S.B., Schaffner S.F., Nguyen H., et al. The structure of haplotype blocks in the human genome. Science 296 5576 (2002) 2225-2229
75. Wacholder S., Rothman N., and Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 92 14 (2000) 1151-1158
76. Wang Y., Localio R., and Rebbeck T.R. Evaluating bias due to population stratification in case-control association studies of admixed populations. Genet Epidemiol 27 1 (2004) 14-20
77. Khoury M.J., and Beaty T.H. Applications of the case-control method in genetic epidemiology. Epidemiol Rev 16 1 (1994) 134-150
78. Andrieu N., and Goldstein A.M. Epidemiologic and genetic approaches in the study of gene-environment interaction: an overview of available methods. Epidemiol Rev 20 2 (1998) 137-147
79. Gong M.N., Thompson B.T., Williams P., et al. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 33 6 (2005) 1191-1198
80. Parsons P.E., Eisner M.D., Thompson B.T., et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 33 1 (2005) 1-6 [discussion: 230-2]
81. Pelosi P., D'Onofrio D., Chiumello D., et al. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl 42 (2003) 48S-56S
82. Negri E.M., Hoelz C., Barbas C.S., et al. Acute remodeling of parenchyma in pulmonary and extrapulmonary ARDS. An autopsy study of collagen-elastic system fibers. Pathol Res Pract 198 5 (2002) 355-361
83. Ely E.W., Wheeler A.P., Thompson B.T., et al. Recovery rate and prognosis in older persons who develop acute lung injury and the acute respiratory distress syndrome. Ann Intern Med 136 1 (2002) 25-36
84. Moss M., Guidot D.M., Steinberg K.P., et al. Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med 28 7 (2000) 2187-2192
85. Moss M., Parsons P.E., Steinberg K.P., et al. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med 31 3 (2003) 869-877
86. Burnham E, Moss M. Translational research: basic concepts and the importance of heterogeneity. Available at: https://www.thoracic.org/sections/clinical-information/critical-care/cri tical-care-research/translational-research.html. Accessed February 17, 2006.
87. Wechsler M.E., Lehman E., Lazarus S.C., et al. beta-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 173 5 (2006) 519-526
88. Camp N.J., Cox A., di Giovine F.S., et al. Evidence of a pharmacogenomic response to interleukin-l receptor antagonist in rheumatoid arthritis. Genes Immun 6 6 (2005) 467-471
89. Niederman M.S. Guidelines for the management of community-acquired pneumonia. Current recommendations and antibiotic selection issues. Med Clin North Am 85 6 (2001) 1493-1509
90. Leufkens H.G., and Urquhart J. Variability in patterns of drug usage. J Pharm Pharmacol 46 Suppl 1 (1994) 433-437
91. Maitland-van der Zee A.H., de Boer A., and Leufkens H.G. The interface between pharmacoepidemiology and pharmacogenetics. Eur J Pharmacol 410 2-3 (2000) 121-130